Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
kpvghkcu
Grey-market vendor blend combining KPV (Lys-Pro-Val, the C-terminal tripeptide of α-MSH) and GHK-Cu (a copper tripeptide). This blend is not clinically validated; no human trials of the combination exist, and evidence for each component is extrapolated from preclinical or topical studies.
Proposed (not validated) rationale: KPV has preclinical data suggesting anti-inflammatory activity downstream of melanocortin signaling, mostly from cell and animal models. GHK-Cu has cosmetic-grade evidence for collagen-related gene expression from topical studies. No synergy between the two has been demonstrated in humans.
No clinical trials of the KPV + GHK-Cu combination exist. KPV lacks human efficacy data; GHK-Cu's strongest evidence is topical. Subcutaneous use of the blend is a vendor construct without validated efficacy.
Typical Dose
Varies by vendor
Frequency
Daily
Route
SubQ or Topical
Notes
Total mg reflects summed content.
Aggregated from 2 lab-verified Certificates of Analysis uploaded directly by labs. Purity averages exclude values outside [50%, 100%] to filter unit-misreads.
COAs
2
Verified labs
0
Avg purity
—
Endotoxin tested
50%
This platform provides informational tools only, not medical advice. This information is for educational purposes only. Consult a licensed provider.
Disclosed Labs